Related Experiment Video
Updated: Jan 4, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Multiple roles for HIV broadly neutralizing antibodies.
Barton F Haynes1, Dennis R Burton2,3, John R Mascola4
1Departments of Medicine and Immunology, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. barton.haynes@duke.edu.
Potent broadly neutralizing antibodies show promise for treating and preventing HIV. These antibodies are also crucial for guiding the development of effective HIV vaccines.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Human Immunodeficiency Virus (HIV) remains a significant global health challenge.
- Effective treatments and preventative strategies, including vaccines, are urgently needed.
Purpose of the Study:
- To explore the therapeutic and prophylactic potential of potent broadly neutralizing antibodies (bNAbs) against HIV.
- To investigate the role of bNAbs in informing the design of novel HIV vaccines.
Main Methods:
- Analysis of existing research on bNAb efficacy.
- Review of studies detailing bNAb mechanisms of action.
- Evaluation of bNAb-guided vaccine development strategies.
Main Results:
- Potent bNAbs demonstrate significant potential for both treatment and prevention of HIV infection.
- bNAbs provide critical insights into the viral targets and immune responses necessary for vaccine efficacy.
Conclusions:
- Broadly neutralizing antibodies represent a promising avenue for HIV therapeutic and preventative interventions.
- Understanding bNAb characteristics is essential for advancing rational HIV vaccine design.
More Related Videos
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Retrovirus Life Cycles
Humoral Immune Responses
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...